These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12103443)

  • 1. Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice.
    Mori A; Okuyama K; Horie M; Taniguchi Y; Wadatsu T; Nishino N; Shimada Y; Miyazawa N; Takeda S; Niimi M; Kyushiki H; Kondo M; Mitsumoto Y
    Neurosci Res; 2002 Jul; 43(3):251-7. PubMed ID: 12103443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
    Park SW; Shen X; Tien LT; Roman R; Ma T
    J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
    Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
    J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine.
    Yamada S; Kojima H; Yokoo H; Tsutsumi T; Takamuki K; Anraku S; Nishi S; Inanaga K
    Biol Psychiatry; 1988 Aug; 24(4):399-408. PubMed ID: 3408757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
    Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
    Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies.
    Hirata H; Cadet JL
    J Neurochem; 1997 Aug; 69(2):780-90. PubMed ID: 9231739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
    Itzhak Y; Anderson KL; Ali SF
    Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty.
    Fujikawa A; Noda Y; Yamamoto H; Tanga N; Sakaguchi G; Hattori S; Song WJ; Sora I; Nabeshima T; Katsuura G; Noda M
    PLoS One; 2019; 14(8):e0221205. PubMed ID: 31430310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.
    Jensen KL; Sørensen G; Dencker D; Owens WA; Rahbek-Clemmensen T; Brett Lever M; Runegaard AH; Riis Christensen N; Weikop P; Wörtwein G; Fink-Jensen A; Madsen KL; Daws L; Gether U; Rickhag M
    eNeuro; 2018; 5(3):. PubMed ID: 29911172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
    Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
    J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion.
    Holson RR; Bowyer JF; Clausing P; Gough B
    Brain Res; 1996 Nov; 739(1-2):301-7. PubMed ID: 8955951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine.
    Bäckman C; You ZB; Perlmann T; Hoffer BJ
    Behav Brain Res; 2003 Jul; 143(1):95-100. PubMed ID: 12842300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.